UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results…
Automobili Lamborghini brings Italian artistry to Miami Beach with a uniquely designed Temerario during Art Basel Miami 2025
The first Temerario delivered in the Americas highlights the extensive personalization possibilities…
Vantage Celebrates Dual Wins at the Finance Magnates Awards 2025 in Vietnam and the UK
PORT VILA, Vanuatu , Nov. 28, 2025 /PRNewswire/ -- Vantage celebrates a double win…
The Kia PV5 Passenger Named Family Car of the Year at the 2026 BBC TopGear.com Awards
The Kia PV5 Passenger model honored as BBC TopGear.com’s ‘Family Car of…
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
November 26, 2025 19:00 ET | Source: HUTCHMED (China) Limited HONG KONG…
Indian MedTech Company Makes a Global Mark at PCR London Valves 2025
Presents One-Year Outcomes from the LANDMARK Randomized Controlled TrialVAPI, India, Nov. 25,…
The Volpi Rosse Menarini: The ‘Fantastic Ten’ are ready for the 2025 – 2026 Season
Italian wheelchair basketball team, sponsored by Menarini, was presented to the press…
Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…
GAC Unveils “Four Growth Engines,” Reforging a New GAC at 2025 Guangzhou Auto Show
GUANGZHOU, China, Nov. 21, 2025 /PRNewswire/ -- On November 21, the 23rd Guangzhou…